- Home
- DLTH vs SAVA Comparison
DLTH vs SAVA Comparison
Compare DLTH & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLTH
- SAVA
- Stock Information
- Founded
- DLTH 1989
- SAVA 1998
- Country
- DLTH United States
- SAVA United States
- Employees
- DLTH N/A
- SAVA N/A
- Industry
- DLTH Clothing/Shoe/Accessory Stores
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- DLTH Consumer Discretionary
- SAVA Health Care
- Exchange
- DLTH Nasdaq
- SAVA Nasdaq
- Market Cap
- DLTH 71.0M
- SAVA 70.5M
- IPO Year
- DLTH 2015
- SAVA N/A
- Fundamental
- Price
- DLTH $2.09
- SAVA $2.13
- Analyst Decision
- DLTH Hold
- SAVA Buy
- Analyst Count
- DLTH 1
- SAVA 2
- Target Price
- DLTH $2.75
- SAVA $54.50
- AVG Volume (30 Days)
- DLTH 38.7K
- SAVA 1.1M
- Earning Date
- DLTH 08-28-2025
- SAVA 08-07-2025
- Dividend Yield
- DLTH N/A
- SAVA N/A
- EPS Growth
- DLTH N/A
- SAVA N/A
- EPS
- DLTH N/A
- SAVA N/A
- Revenue
- DLTH $612,649,000.00
- SAVA N/A
- Revenue This Year
- DLTH N/A
- SAVA N/A
- Revenue Next Year
- DLTH N/A
- SAVA N/A
- P/E Ratio
- DLTH N/A
- SAVA N/A
- Revenue Growth
- DLTH N/A
- SAVA N/A
- 52 Week Low
- DLTH $1.58
- SAVA $1.15
- 52 Week High
- DLTH $4.50
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- DLTH 51.30
- SAVA 57.26
- Support Level
- DLTH $2.01
- SAVA $1.91
- Resistance Level
- DLTH $2.33
- SAVA $2.23
- Average True Range (ATR)
- DLTH 0.11
- SAVA 0.11
- MACD
- DLTH 0.01
- SAVA 0.03
- Stochastic Oscillator
- DLTH 42.86
- SAVA 78.12
About DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.